Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210,904 | 287,011 | 115,603 | 45,961 | N/A |
| Marketable Securities | 516 | 567 | 2,872 | 619 | N/A |
| TOTAL | $216,863 | $295,810 | $124,976 | $50,129 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 17,852 | 19,430 | 18,250 | 7,117 | N/A |
| Other Non-Current Assets | 5,422 | 8,040 | 4,658 | 3,467 | 0 |
| TOTAL | $23,274 | $27,470 | $22,908 | $10,584 | $N/A |
| Total Assets | $240,137 | $323,280 | $147,884 | $60,713 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,303 | 10,746 | 7,810 | N/A | N/A |
| Accounts payable and accrued liabilities | 676 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 12,467 | 10,846 | 6,498 | 2,675 | N/A |
| TOTAL | $31,990 | $24,342 | $14,308 | $2,675 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,743 | 8,529 | 7,958 | N/A | N/A |
| Other Non-Current Liabilities | 1,937 | 3,655 | 215,714 | 101,116 | 0 |
| TOTAL | $8,680 | $12,184 | $223,672 | $101,116 | $N/A |
| Total Liabilities | $40,670 | $36,526 | $237,980 | $103,791 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 32 | 35 | 10 | 10 | N/A |
| Retained earnings | -235,644 | -159,711 | -86,441 | -42,623 | N/A |
| Other shareholders' equity | 10,661 | -9,091 | -3,665 | -465 | 0 |
| TOTAL | $199,467 | $286,754 | $-90,096 | $-43,078 | $N/A |
| Total Liabilities And Equity | $240,137 | $323,280 | $147,884 | $60,713 | $0 |